Key points are not available for this paper at this time.
Introduction Lung cancer remains the leading cause of cancer-related mortality globally, with current screening methods like low-dose computed tomography (LDCT) limited by radiation risks and false negatives. Non-invasive diagnostic tools are urgently needed. Methods We developed a deep-cough swab protocol coupled with rapid RNA extraction and direct RT-qPCR to detect human telomerase reverse transcriptase (hTERT) mRNA in airway secretions. The assay was validated using exosomes from lung cancer cell lines and applied to 300 participants (106 early-stage lung cancer patients, 142 benign pulmonary nodule cases, and 52 healthy controls). Results The assay achieved 90.6% sensitivity (95% CI: 85.1%–96.2%) for stage IA lung cancer and 95.9% specificity (95% CI: 93.1%–98.7%) in non-cancer controls. ROC analysis demonstrated excellent discrimination (AUC = 0.97, p 0.0001). Sensitivity was consistent across histological subtypes and unaffected by smoking status (p 0.05). Conclusion Deep-cough swab detection of hTERT mRNA provides a clinically viable, non-invasive method for auxiliary diagnosis of early-stage lung cancer, potentially complementing CT screening for pulmonary nodule management.
Liu et al. (Thu,) studied this question.